Migraine headaches: A brief overview: A brief overview

Natalie Schellack*, O. Mogole, N. Magongwa, Nkatoko Freddy Makola

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review


© Medpharm This article aims to provide a concise, high-level overview of the classification, management and treatment of migraine. Migraine is a common, debilitating neurological disorder that is characterised by the presence of severe headaches, which may last anything from a few hours to a few days (4-72 hours). Thus, the condition is characterised by episodes of severe migraine headache, frequently accompanied by nausea and vomiting. These headaches may be unilateral or bilateral and patients may also experience a range of associated features. Acute attacks require rapid, abortive treatment and the rate of recurrence needs to be reduced and managed through the use of effective prophylactic measures.
Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalSA Pharmaceutical Journal
Issue number1
Publication statusPublished - 1 Jan 2019


  • Aura
  • Ergot alkaloids
  • Headache
  • Migraine
  • Triptans


Dive into the research topics of 'Migraine headaches: A brief overview: A brief overview'. Together they form a unique fingerprint.

Cite this